Abstract: Objective To investigate the expression of alpha-fetoprotein (AFP) and Golgi protein 73(GP73) in serum of patients with primary hepatic cancer (PHC) and healthy people, and analyze their clinical significance. Methods Retrospective analysis of classification and possible risk factors were preformed in PHC patients. Serum AFP and GP73 levels of 37 PHC patients and 38 healthy people were detected by electrochemiluminescence and ELISA. The sensitivity and specificity of serum AFP, GP73 and AFP + GP73 in diagnosis of PHC were analyzed. Results In PHC patients, there were 91.89% (34/37) of HCC patients, and 75.68% (28/37) PHC patients had a viral hepatitis history. The serum levels of AFP and GP73 in PHC patients [(418.31 ± 189.93) ng/ml, (252.03 ± 238.34) ng/ml] were significantly higher than that in healthy people [(16.28 ± 9.39) ng/ml, (34.03 ± 22.67) ng/ml] (all P < 0.01). The sensitivity and specificity value of AFP combined with GP73 reached 86.49% and 84.20%, respectively. Compared with AFP and GP73 alone, AFP combined with GP73 had higher diagnosis accuracy on PHC. Conclusions Serum levels of AFP and GP73 were important factors for PHC genesis and development. AFP combined with GP73 detection has important significance for PHC diagnosis and prognosis estimation.
|